Patient info Open main menu

Ultra Chloraseptic Sore Throat Pain Relief Winter Spice Flavour 0.71% w/v Oromucosal spray – patient leaflet, side effects, dosage

Text from the MHRA, as of · About this document

Medicine strength:
0.71% w/v
Contains active substance:
ATC code:

Patient leaflet - Ultra Chloraseptic Sore Throat Pain Relief Winter Spice Flavour 0.71% w/v Oromucosal spray

1. What Ultra Chloraseptic® Sore Throat Pain Relief 0.71% w/v Oromucosal Spray is and what it is used for

Ultra Chloraseptic® Sore Throat Pain Relief

Winter Spice Flavour 0.71% w/v Oromucosal Spray is used to relieve sore throat pain and will be referred to as Ultra Chloraseptic® Sore Throat Pain Relief 0.71% w/v Oromucosal Spray throughout this leaflet. The product contains the active ingredient benzocaine which belongs to the group of medicines called local anaesthetics. It has a fast action and works by numbing the pain of a sore throat. The product comes in the form of a spray. It has a swivel head applicator to help deliver the local anaesthetic direct to the throat.

2. What you need to know before you use Ultra Chloraseptic® Sore Throat Pain Relief 0.71% w/v Oromucosal Spray

DO NOT use this spray if:

•

or doctor if this applies to you• you know you are allergic to benzocaine or any of the other ingredients (see Section 6)

you have difficulty in breathing, noisy breathing or severe difficulty in swallowing. Talk to your pharmacist

  • you have been told that you have a rare blood condition called methaemoglobinaemia
  • you are pregnant or breast-feeding

Warnings and precautions:

DO NOT use this medicine for children under 6 years of age.

If your sore throat is severe or prolonged, or accompanied by fever, headache, or feeling sick, consult a doctor.

Ultra Chloraseptic® Sore Throat Pain Relief 0.71% w/v Oromucosal Spray contains alcohol and propylene glycol

This medicine contains a small quantity of alcohol (less than 0.006 units per spray) to dissolve the other ingredients. Contains propylene glycol - this may cause skin irritation.

3. How to use Ultra Chloraseptic® Sore Throat Pain Relief 0.71% w/v Oromucosal Spray

Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Ultra Chloraseptic® Sore Throat Pain Relief 0.71% w/v Oromucosal Spray is for use by adults and teenagers, and children aged from 6 years when supervised by an adult. The product is designed so that the medication can be sprayed directly to the back of the throat. The following instructions will help you to get the best results from your spray:

  • Remove the cap from the bottle, and rotate the spray head around by half a circle so that the nozzle extends beyond the bottle (see diagram below).
  • If this is a new bottle, or you have not used it since your last sore throat, activate the pump by spraying 3 times away from your face into a sink. This will also help you to get a feel for the pump action.

    Continued overleaf Nozzle in stored position Nozzle ready for use

  • How to use (CONTINUED)
  • Hold the bottle in your hand with your index
  • When you are ready, open the mouth a little and point the spray nozzle towards the back of

    your throat. The nozzle should be just inside your mouth (see diagram below). This will help the spray get to its target at the back of the throat.

  • Hold your breath and then press the

pump to spray. Do not exceed the dosage on the labelling.• front of the mirror whilst spraying the product. Spray Dosage:

DO NOT spray into the eyes. If you accidentally spray into your eyes, rinse them thoroughly under water.

For Adults and Teenagers:

  • Hold breath and spray 3 times to the back of your throat.
  • Repeat every 2-3 hours if required.
  • Do not use more than 8 times a day.

For Children 6-12 years:

  • Use only under adult supervision.
  • Do not use in a child who is unable to hold their breath whilst spraying.
  • Hold breath and spray once to the back of the throat.
  • Repeat every 2-3 hours if required.
  • Do not use more than 8 times a day.

DO NOT use for more than 3 days in a row. If symptoms do not improve, consult your pharmacist or doctor.

You should experience temporary numbness in your throat after using the spray. This indicates that the product is working. Avoid eating or drinking as long as the numbness lasts.

If you spray more than you should, and you feel drowsy, you must contact a doctor immediately.

4. Possible side effects

Allergic reactions have been reported occasionally with benzocaine. Although very unlikely, if your breathing is affected after using the spray, or if your face or mouth become swollen, stop using the spray and seek immediate medical advice.

Methaemoglobinaemia (a very rare blood condition) has been reported with benzocaine use.

Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This

You can also report side effects directly via the Yellow Card Scheme:

Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Ultra Chloraseptic® Sore Throat

Pain Relief 0.71% w/v Oromucosal Spray Keep out of the sight and reach of children.

This medicinal product does not require any special storage conditions.

Do not use the spray after the Expiry date which is shown on the top of the carton and on the base of the spray bottle.

6. Contents of the pack and other information

What Ultra Chloraseptic® Sore Throat Pain Relief 0.71% w/v Oromucosal Spray contains

The spray contains Benzocaine 0.71% w/v (1mg per spray) as the active ingredient. It also contains: ethanol, macrogol 300, propylene glycol, glycerol, cetylpyridinium chloride, saccharin sodium, sodium dihydrogen phosphate

What Ultra Chloraseptic® Sore Throat Pain Relief 0.71% w/v Oromucosal Spray looks like and contents of pack

The spray is a clear colourless to straw coloured solution, presented in a glass bottle with a spray nozzle under a plastic cap. Each bottle contains 15ml. The nozzle is used to target the spray to the back of the throat.

The marketing authorisation for Ultra Chloraseptic®

Sore Throat Pain Relief Winter Spice Flavour 0.71% w/v Oromucosal Spray is held by: Prestige Brands (UK) Ltd, 5-7 London Road, St. Albans,

AL1 1LA, United Kingdom.

The product is manufactured at: Wagener & Co GmbH, Poststrasse 24, 49525 Lengerich, Germany.

This leaflet is dated October 2025

XXXXXXXXX UCWS1V1

© Prestige Brands (UK) Limited 2025.

® Chloraseptic is a registered trademark.

line on 0800 198 5000 and quote PL 18259/0014

Press pump

to spray

(first) finger on the pump, ready to spray. includes any possible side effects not listed in this leaflet.

cool mint, garden mint, levomenthol), and purified water. dihydrate, sodium hydroxide, flavourings (winter spice,

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 18259/0014

MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Ultra Chloraseptic Sore Throat Pain Relief Winter Spice Flavour 0.71% w/v Oromucosal spray

Active substance Benzocaine
Strength 0.71% w/v
Pharmaceutical form Direct application to the throat by
spraying Clear, colourless to straw
coloured liquid
Excipients Ethanol, Macrogol 300, Propylene glycol, Glycerol, Cetylpyridinium chloride, Levomenthol, Saccharin sodium, Winter spice flavour, Mint (cool) flavour, Garden Mint flavour, Sodium dihydrogen phosphate dihydrate, Sodium hydroxide, Purified water
Shelf life 36 months.
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC)
  1. R Respiratory system drugs
    1. R02 Throat preparations
      1. R02A Throat preparations
        1. R02AD Local anesthetic throat preparations
          1. R02AD01 benzocaine
Marketing authorisation PL 18259/0014 (first authorised 4 April 2025)
Marketing authorisation holder Prestige Brands (UK) Limited

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.